• Overview of hemolytic uremic syndrome in children
  View in Chinese
  • Diagnosis
  • Shiga toxin-producing E. coli (STEC)
  • Summary and recommendations
• Complement-mediated hemolytic uremic syndrome
  View in Chinese
  • Diagnosis
  • Clinical manifestations
  • Summary and recommendations
• Treatment and prognosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome (HUS) in children
  View in Chinese
  • Management overview
  • Summary and recommendations
• Clinical manifestations and diagnosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome (HUS) in children
  View in Chinese
  • Differential diagnosis
  • Classification
  • Summary and recommendations
• Approach to the patient with suspected TTP, HUS, or other thrombotic microangiopathy (TMA)
  View in Chinese
  • Key distinguishing features among the primary TMA syndromes
  • Summary and recommendations
• Pathophysiology of acquired TTP and other primary thrombotic microangiopathies (TMAs)
  View in Chinese
  • Complement-mediated TMA pathogenesis
  • Shiga toxin-induced TMA (ST-HUS)
  • Summary
• Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection
  • Hemolytic-uremic syndrome
  • Summary and recommendations
• Recurrent and de novo HUS after renal transplantation
  • Recurrent HUS
  • De novo HUS
  • Summary and recommendations
• Approach to the child with acute diarrhea in resource-limited countries
  View in Chinese
  • Hemolytic uremic syndrome
  • Summary
• Acquired TTP: Initial treatment
  View in Chinese
  • Overview for HUS
  • Summary and recommendations
• Approach to diarrhea in children in resource-rich countries
  View in Chinese
  • Hemolytic uremic syndrome
  • Summary
• Lower gastrointestinal bleeding in children: Causes and diagnostic approach
  View in Chinese
  • Hemolytic-uremic syndrome
  • Summary and recommendations
• Acquired TTP: Clinical manifestations and diagnosis
  View in Chinese
  • Differential diagnosis
  • Neurologic and other organ involvement
  • Summary and recommendations
• Acute kidney injury (acute renal failure) in pregnancy
  View in Chinese
  • Thrombotic thrombocytopenic purpura or hemolytic uremic syndrome
  • Summary and recommendations
• Thrombocytopenia in pregnancy
  View in Chinese
  • Thrombotic microangiopathy (TMA)
  • Summary and recommendations
• Critical illness during pregnancy and the peripartum period
  View in Chinese
  • TTP and HUS
  • Summary and recommendations
• Mitomycin-C pulmonary toxicity
  • Thrombotic microangiopathy and acute respiratory failure
  • Summary and recommendations
• Evaluation of purpura in children
  View in Chinese
  • Hemolytic uremic syndrome
  • Summary
• Complications of renal transplantation in children
  View in Chinese
  • Hemolytic uremic syndrome
  • Summary and recommendations
• Shigella infection: Clinical manifestations and diagnosis
  View in Chinese
  • Hemolytic-uremic syndrome
  • Summary
• Cerebrovascular disorders complicating pregnancy
  View in Chinese
  • Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
  • Summary and recommendations
• Preeclampsia: Clinical features and diagnosis
  View in Chinese
  • AFLP, TTP, HUS, SLE
  • Summary and recommendations
• Treatment-related toxicity in men with testicular germ cell tumors
  View in Chinese
  • Hemolytic uremic syndrome
  • Summary
• Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)
  View in Chinese
  • Pathogenesis
  • Microbiology
  • Summary
• Pathogenic Escherichia coli
  View in Chinese
  • Enterohemorrhagic Escherichia coli (EHEC)
  • Summary
• Drug-induced thrombotic microangiopathy
  View in Chinese
  • Differential diagnosis
  • Epidemiology
  • Summary and recommendations
• Kidney disease following hematopoietic cell transplantation
  View in Chinese
  • Overview
  • Thrombotic microangiopathy
  • Summary and recommendations
• Approach to the child with unexplained thrombocytopenia
  View in Chinese
  • History
  • Summary and recommendations
• Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults
  View in Chinese
  • DIC versus other TMAs
  • Summary and recommendations
• Causes of thrombocytopenia in children
  View in Chinese
  • Platelet activation and consumption
  • Summary
• General principles of renal transplantation in children
  View in Chinese
  • Renal transplantation
  • Summary and recommendations
• Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis
  View in Chinese
  • Complement-mediated MPGN
  • Summary
• Emergent evaluation of the child with acute abdominal pain
  View in Chinese
  • Associated symptoms
  • Laboratory studies
  • Summary and recommendations
• What's new in hematology
  • Discontinuation of eculizumab in complement-mediated hemolytic uremic syndrome (June 2017)
• Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism
  View in Chinese
  • Thrombotic microangiopathy
  • Fragmentation hemolysis
  • Summary and recommendations
• HELLP syndrome
  View in Chinese
  • Differential diagnosis
  • Summary and recommendations
• Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities
  View in Chinese
  • Abnormalities of the coagulation system
  • Secondary causes of thrombocytopenia
  • Summary and Recommendations
• Rectal prolapse in children
  View in Chinese
  • Diarrheal disease
  • Summary
• Antiphospholipid syndrome and the kidney
  View in Chinese
  • Renal disease in primary antiphospholipid syndrome
  • Renal transplantation
  • Summary and recommendations
• Cyclosporine and tacrolimus nephrotoxicity
  View in Chinese
  • Tacrolimus nephrotoxicity
  • Acute calcineurin inhibitor nephrotoxicity
  • Summary and recommendations
• Pharmacology of mammalian (mechanistic) target of rapamycin (mTOR) inhibitors
  View in Chinese
  • Hemolytic uremic syndrome/thrombotic microangiopathy
  • Summary and recommendations
• What's new in pediatrics
  • Discontinuation of eculizumab in complement-mediated hemolytic uremic syndrome (June 2017)
• Approach to the adult with acute diarrhea in resource-limited countries
  View in Chinese
  • Complications of acute diarrheal diseases in adults
  • Summary and recommendations
• Reversible posterior leukoencephalopathy syndrome
  View in Chinese
  • Hypertension
  • Endothelial dysfunction
  • Summary and recommendations
• Evaluation of jaundice caused by unconjugated hyperbilirubinemia in children
  View in Chinese
  • Anemia and/or hemolysis
  • Summary and recommendations
• Clostridium difficile infection in children: Microbiology, pathogenesis, and epidemiology
  • Predisposing conditions
  • Summary
• Evaluation of pallor in children
  • Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP)
  • Summary
• Anemia and the renal transplant recipient
  View in Chinese
  • Immunosuppression
  • Diagnostic evaluation
  • Summary and recommendations
• Clinical manifestations of antiphospholipid syndrome
  View in Chinese
  • Hematologic abnormalities
  • Summary and recommendations
• Disseminated intravascular coagulation in infants and children
  View in Chinese
  • Thrombocytopenia and normal coagulation tests
  • Summary and recommendations

Topic Outline Hide Topic Outline Show Graphics (0)